Teva May Have to Make Difficult Capital Allocation Decisions Under Pressure From Potential Generic Competition, Deleveraging Goals - Reorg
![Teva Pharmaceuticals on Twitter: "Congratulations to Teva's Head of NA Commercial, Brendan O'Grady, for his appointment by @CommerceGov to serve on the U.S. Investment Advisory Council. https://t.co/bANDSZUNSv https://t.co/bD0dvQGp8D" / Twitter Teva Pharmaceuticals on Twitter: "Congratulations to Teva's Head of NA Commercial, Brendan O'Grady, for his appointment by @CommerceGov to serve on the U.S. Investment Advisory Council. https://t.co/bANDSZUNSv https://t.co/bD0dvQGp8D" / Twitter](https://pbs.twimg.com/media/EDkRC1XWwAA3K2v.jpg)
Teva Pharmaceuticals on Twitter: "Congratulations to Teva's Head of NA Commercial, Brendan O'Grady, for his appointment by @CommerceGov to serve on the U.S. Investment Advisory Council. https://t.co/bANDSZUNSv https://t.co/bD0dvQGp8D" / Twitter
![Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire](https://mms.businesswire.com/media/20211027005515/en/739014/22/teva_RGB_JPEG.jpg)